Shizuo Kasai

This inventor holds 14 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 6 EPO patents. Top assignees: Takeda Pharmaceutical Company Limited, Scohia Pharma, Inc.. Active years: 2012-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shizuo Kasai. Retrieved from https://idiyas.com/inventor/shizuo-kasai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 1)

% Patents Active = 50.0

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 14)

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 42(Granted Patents)

Location History:

Osaka, JP (2012 - 2016)
Kanagawa, JP (2014 - 2021)
Fujisawa, JP (2017 - 2021)

Company Filing History:

14 out of 1,229

Takeda Pharmaceutical Company Limited

where one patent can have more than one assignee

Years Active: 2012-2021

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11186565 - Aromatic compound (2021-11-30),

2. 10968231 - Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disorders (2021-04-06),

3. 10968178 - IP6K inhibitors (2021-04-06),

4. 9751878 - Tetrahydronaphthyridine somatostatin receptor 5 antagonists (2017-09-05),

5. 9605000 - Spiro azetidine isoxazole derivatives and their use as SSTR antagonists (2017-03-28),

6. 9505772 - Aromatic ring compound (2016-11-29),

7. 9487509 - Heterocyclic compound (2016-11-08),

8. 9440987 - Aromatic ring compound (2016-09-13),

9. 9365540 - Benzimidazole derivatives as MCH receptor antagonists (2016-06-14),

10. 9353108 - Tetrahydronaphthyridine somatostatin receptor 5 antagonists (2016-05-31),

11. 9120777 - Heterocyclic compound (2015-09-01),

12. 8853215 - Derivatives of N-acyl-N'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes (2014-10-07),

13. 8586571 - Heterocyclic compound (2013-11-19),

14. 8338622 - Heterocyclic compound (2012-12-25),

Title: The Innovations of Shizuo Kasai

Introduction

Shizuo Kasai is a prominent inventor based in Kanagawa, Japan, who has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 14 patents, he has focused on developing novel compounds aimed at addressing various health issues such as cancer, obesity, diabetes, and more.

Latest Patents

Among his latest inventions, two notable patents stand out. The first is an aromatic compound that is characterized by its potential GPR40 agonist activity and GLP-1 secretagogue action. This novel aromatic ring compound may be beneficial in the prevention or treatment of several conditions including cancer, obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, and metabolic syndrome, showcasing its superior efficacy.

The second noteworthy patent involves IP6K inhibitors. This invention provides a heterocyclic compound known for its IP6K inhibitory action, which is anticipated to serve as a prophylactic or therapeutic agent for various diseases, particularly cardiac failure and diabetes. These advancements reflect Dr. Kasai's dedication to pioneering solutions for complex medical challenges.

Career Highlights

Throughout his esteemed career, Shizuo Kasai has collaborated with and contributed to some of the foremost pharmaceutical companies in the industry. Notably, he has worked with Takeda Pharmaceutical Company Limited and Scohia Pharma, Inc., where his innovations have significantly impacted the development of therapeutic agents.

Collaborations

In addition to his corporate affiliations, Dr. Kasai has collaborated with esteemed colleagues, including Asato Kina and Takeshi Yamasaki. These partnerships have facilitated the sharing of knowledge and expertise, further enhancing the innovation processes within their respective fields.

Conclusion

Shizuo Kasai stands out as a distinguished inventor whose work is paving the way for new therapeutic interventions. His latest patents not only demonstrate his inventive spirit but also highlight his commitment to improving public health through innovative medical solutions. As the world continues to face complex health challenges, the contributions of inventors like Shizuo Kasai remain crucial.

Profile summary based on public USPTO records.